Coordinator(s)/scientist(s)

Disease Area

DZL Partner Site(s) involved

Title

Behr J / Günther A Diffuse Parenchymal Lung Disease (DPLD) all Exploratory efficacy and safety study of oral pirfenidone for progressive, non-IPF lung fibrosis (RELIEF in lung fibrosis)
Griese M Diffuse Parenchymal Lung Disease (DPLD) all Hydroxychloroquine (HCQ) in pediatric ILD (= children‘s interstitial lung disease; chILD)
Herold S Pneumonia and Acute Lung Injury BREATH, UGMLC GM-CSF Inhalation to improve HOst defense and Pulmonary barrier rEsoration (GI-HOPE)
Herold S / Lohmeyer J / Welte T Pneumonia and Acute Lung Injury BREATH, UGMLC Promotion of host defense and alveolar barrier regeneration by inhaled GM-CSF in patients with pneumonia-associated ARDS
Heußel C Lung Cancer BREATH, CPC-M, TLRC, UGMLC Early response capturing in the treatment of adenocarcinoma
Jobst B COPD all Imaging disease progression in COP
Kreuter M / Vogelmeier C / Herth F COPD TLRC, UGMLC Exploring efficacy of peridontal treatment on systemic inflammation and for prevention of exacerbations in patients with COPD: A multi-center, prospective, randomized, controlled, parallel-group pilot study
Reck M / Ammerpohl O / Barreto G Lung Cancer all Monitoring of patients with NLCLC – epigenetic analysis of liquid biopsies and RNA-analysis in exhaled breath condensates
Schulz H / Meiners S / Vogelmeier C / Behr J COPD CPC-M, UGMLC Proteasom Function as a Bio-Marker for COPD
Seeger W / Ghofrani A / Gall H Pulmonary Hypertension BREATH, UGMLC Influence of specific PAH medication on right ventricular function in patients with pulmonary arterial hypertension
Tümmler B Cystic Fibrosis / Mucoviscidosis BREATH, TLRC, UGMLC Orkambifacts – Intestinal current measurements (ICM) to evaluate the activation of mutant CFTR in treated with lumacaftor in combination with ivacaftor.
Vogel-Claussen J Radiology / Pulmonale Hypertronie BREATH, CPC-M, UGMLC, TLRC Change-MRI – Phase III diagnostic trial to demonstrate that functional lung MRI can replace VQ-SPECT in a diagnostic strategy for patients with suspected CTEPH.
Vogelmeier C  COPD ARCN, BREATH, UGMLC Clinical study to investigate safety, tolerability, efficacy, pharmacokinetics and pharmacodynamics of multiple doses of the human GATA-3-specific DNAzyme solution SB010 in patients with moderate to severe COPD – A randomised, double-blind, parallel, multicentre, phase IIa pilot study
Zabel P / Herth F / König I / Rabe K / Welte T  COPD ARCN, BREATH, TLRC Evaluation of non-invasive pursed-lip breathing ventilation in advanced COPD

 

Cookies make it easier for us to provide you with our services. With the usage of our services you permit us to use cookies.
More information Ok